Overview

Intramuscular or Intravenous Tranexamic Acid for the Prevention of Heavy Bleeding After Childbirth in Women at Increased Risk

Status:
Not yet recruiting

Trial end date:
2025-09-01

Target enrollment:

Participant gender:

Summary

Heavy bleeding after childbirth, known as a postpartum haemorrhage (PPH), causes about 70,000 maternal deaths every year. Tranexamic acid (TXA) is a lifesaving treatment for women with PPH. The I'M WOMAN trial is a research study to see whether giving TXA just before childbirth will stop women developing PPH. The trial will assess the effects of intramuscular (IM) and intravenous (IV) tranexamic acid on PPH, side effects and other important maternal health outcomes.

Phase:

Phase 3

Details

Lead Sponsor:

London School of Hygiene and Tropical Medicine

Collaborator:

UNITAID

Treatments:

Tranexamic Acid